INVO Bioscience News

INVO Bioscience | 8-K: Current report

May 6 17:35 ET

INVO Bioscience | 10-K/A: Annual report (Amendment)

Apr 29 16:46 ET

INVO Bioscience | 8-K: Current report

Apr 19 17:21 ET

INVO Bioscience | 10-K/A: Annual report (Amendment)

Apr 17 17:05 ET

INVO Bioscience | 8-K: Current report

Apr 17 15:20 ET

INVO Bioscience | 8-K: INVO Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 16 17:01 ET

INVO Bioscience | 10-K: Annual report

Apr 16 16:56 ET

INVO Bioscience | 8-K: Current report

Apr 11 17:33 ET

INVO Bioscience | 8-K/A: Current report (Amendment)

Apr 2 17:21 ET

INVO Bioscience | NT 10-K: Others

Apr 1 16:24 ET

INVO Bioscience | 8-K: Current report

Apr 1 16:10 ET

INVO Bioscience | 424B5: Prospectus

Mar 29 16:43 ET

INVO Bioscience | 10-K/A: Annual report (Amendment)

Mar 27 17:25 ET

INVO Bioscience | 8-K: Current report

Mar 1 17:21 ET

INVO Bioscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(6.9%),Daniel B. Asher(6.9%), etc.

Feb 6 10:27 ET

INVO Bioscience | 8-K: Current report

Feb 1 09:06 ET

INVO Bioscience | S-4: Registration of securities issued in business combination transactions

Jan 16 00:00 ET

INVO Bioscience | 8-K/A: Current report (Amendment)

Jan 10 00:00 ET

INVO Bioscience | 8-K: Current report

Jan 10 00:00 ET

INVO Bioscience | 8-K: Current report

Jan 3 00:00 ET